• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS NUSSLOCH GMBH LEICA ASP300S

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS NUSSLOCH GMBH LEICA ASP300S Back to Search Results
Model Number 14047643514
Device Problems Human Factors Issue (2948); Therapeutic or Diagnostic Output Failure (3023)
Patient Problem Tissue Damage (2104)
Event Date 04/13/2018
Event Type  Injury  
Manufacturer Narrative
An investigation of the incident is currently underway and a follow up will be submitted should additional information become available following the investigation.
 
Event Description
The customer reported that on (b)(6) 2018 they experienced suboptimal tissue processing on their asp300s.As a result five biopsies were undiagnosable.A re-biopsy was recommended, but to date the patients have been received no re-biopsy.
 
Manufacturer Narrative
The investigation revealed the following: the incident was presumably user related due to a wrong application from the customer site.The logs of the affected unit has been investigated by a leica application & product specialist.The analysis of the instrument revealed that there was no technical failure of the device found which would have led to nondiagnosable tissues.The analysis showed that the customer began the tissue processing with a delay step in the first alcohol (70%).It is not recommended to start processing tissue in alcohol because this may dehydrate the tissue and cause it to become hard/brittle, especially when set in a delay step over a weekend.In addition, there is a pressure and vacuum step in every step.This makes sense only in the wax step.Otherwise, the high pressure can overstress the tissue and could be damaged.These protocol issues are not recommended and caused the suboptimal processed tissues.A customer facing letter will be send to the customer with a recommendation in the future of how to properly care for the tissues, and to modify the protocol regarding the improvement of the tissue quality during the processing with the tissue processor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEICA ASP300S
Type of Device
ASP300S
Manufacturer (Section D)
LEICA BIOSYSTEMS NUSSLOCH GMBH
heidelbergerstr. 17-19
nussloch, 69226
GM  69226
Manufacturer Contact
robert gropp
heidelbergerstr. 17-19
nussloch, 69226
GM   69226
MDR Report Key7513574
MDR Text Key108226541
Report Number8010478-2018-00002
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number14047643514
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/18/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/31/2007
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-